Michael S. Willett

New President and Premises in Princeton, NJ

The Harrison Clinical Research Group is pleased to welcome Michael S. Willett, PharmD, as President & Managing Director of HCRAmerica. Dr. Willett has worked for the past 20 years in CRO and pharmaceutical companies in the USA, and HCR is looking forward to benefiting from his experience in CRO business development and marketing, as a senior clinical research scientist, in regulatory affairs consultancy, project management, medical writing and data interpretation and in all major therapeutic areas and indications. Dr. Willett previously founded Advanced Biomedical Research, Inc. (ABR) and successfully grew the organisation as a scientifically driven North American-based CRO. He also previously worked at Bristol-Myers Squibb and Marion Laboratories (now part of Sanofi-Aventis). Dr. Willett received his Doctor of Pharmacy degree with honors from the University of Illinois at Chicago and completed a post-PharmD residency in adult internal medicine at Truman Medical Centre and the University of Missouri-Kansas City.
Dr. Willett and his HCR colleagues will be pleased to meet you at booth number 1330 at the DIA meeting in San Diego, CA, June 21-25, to discuss how HCRAmerica can assist you with your upcoming clinical trials. Alternatively, why not give him a call or e-mail him using the button below.

HCRAmerica
116 Village Blvd, Suite 200
Princeton, NJ 08540
Tel: +1 609 734 7442
Fax: +1 609 520 1702

ContactMichael S. Willett,
President & Managing Director of HCRAmerica